First-pass Metabolism of Decursin, a Bioactive Compound of Angelica gigas, in Rats

Abstract

Decursin is considered the major bioactive compound of Angelica gigas roots, a popular Oriental herb and dietary supplement. In this study, the pharmacokinetics of decursin and its active metabolite, decursinol, were evaluated after the administration of decursin in rats. The plasma concentration of decursin decreased rapidly, with an initial half-life of 0.05 h. It was not detectable at 1 h after intravenous administration at an area under the plasma concentration-time curve of 1.20 µg · mL⁻¹·h, whereas the concentration of decursinol increased rapidly reaching a maximum concentration of 2.48 µg · mL⁻¹ at the time to maximum plasma concentration of 0.25 h and an area under the plasma concentration-time curve of 5.23 µg · mL⁻¹·h. Interestingly, after oral administration of decursin, only decursinol was present in plasma, suggesting an extensive hepatic first-pass metabolism of decursin. The extremely low bioavailability of decursin after its administration via the hepatic portal vein (the fraction of dose escaping first-pass elimination in the liver, F_H = 0.11) is indicative of extensive hepatic first-pass metabolism of decursin, which was confirmed by a tissue distribution study. These findings suggest that decursin is not directly associated with the bioactivity of A. gigas and that it may work as a type of natural prodrug of decursinol.

Key words

decursin - decursinol - first-pass metabolism - absorption barrier - Angelica gigas Nakai - Apiaceae

• References

• 1 Jung DJ, Porzel A, Huneck S. Gigasol and other coumarins from Angelica gigas . Phytochemistry 1991; 30: 710-712
• 2 Zhao KJ, Dong TT, Tu PF, Song ZH, Lo CK, Tsim KW. Molecular genetic and chemical assessment of radix Angelica (Danggui) in China. J Agric Food Chem 2003; 51: 2576-2583
• 3 Konoshima M, Chi HJ, Hata K. Coumarins from the root of Angelica gigas Nakai. Chem Pharm Bull 1968; 16: 1139-1140
• 4 Sarker SD, Nahar L. Natural medicine: the genus Angelica . Curr Med Chem 2004; 11: 1479-1500
• 5 Kim KY, Lee S, Cha CJ. Biotransformation of plant secondary metabolite decursin by Mycobacterium sp. PYR1001. J Agric Food Chem 2010; 58: 2931-2934
• 6 Lee S, Kang SS, Shin KH. Coumarins and a pyrimidine from Angelica gigas roots. Nat Prod Sci 2002; 8: 58-61
• 7 Ahn MJ, Lee MK, Kim YC, Sung SH. The simultaneous determination of coumarins in Angelica gigas root by high performance liquid chromatography-diode array detector coupled with electrospray ionization/mass spectrometry. J Pharm Biomed Anal 2008; 46: 258-266
• 8 Kang SY, Lee KY, Park MJ, Kim YC, Markelonis GJ, Oh TH, Kim YC. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice. Neurobiol Learn Mem 2003; 79: 11-18
• 9 Kang SY, Lee KY, Sung SH, Park MJ, Kim YC. Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: structure-activity relationships. J Nat Prod 2001; 64: 683-685
• 10 Kang SY, Lee KY, Koo KA, Yoon JS, Lim SW, Kim YC, Sung SH. ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice. Life Sci 2005; 76: 1691-1705
• 11 Yan JJ, Kim DH, Moon YS, Jung JS, Ahn EM, Baek NI, Song DK. Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 25-30
• 12 Lee S, Lee YS, Jung SH, Shin KH, Kim BK, Kang SS. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas . Arch Pharm Res 2003; 26: 727-730
• 13 Choi SS, Han KJ, Lee HK, Han EJ, Suh HW. Antinociceptive profiles of crude extract from roots of Angelica gigas NAKAI in various pain models. Biol Pharm Bull 2003; 26: 1283-1288
• 14 Choi SS, Han KJ, Lee JK, Lee HK, Han EJ, Kim DH, Suh HW. Antinociceptive mechanisms of orally administered decursinol in the mouse. Life Sci 2003; 73: 471-485
• 15 Lee YY, Lee S, Jin JL, Yun-Choi HS. Platelet anti-aggregatory effects of coumarins from the roots of Angelica genuflexa and A. gigas . Arch Pharm Res 2003; 26: 723-726
• 16 Lee S, Shin DS, Kim JS, Oh KB, Kang SS. Antibacterial coumarins from Angelica gigas roots. Arch Pharm Res 2003; 26: 449-452
• 17 Yang EJ, Song GY, Lee JS, Yun CY, Kim IS. A novel (S)-(+)-decursin derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]chromen-3-yl-ester, inhibits ovalbumin-induced lung inflammation in a mouse model of asthma. Biol Pharm Bull 2009; 32: 444-449
• 18 Herath W, Reddy N, Khan IA. Microbial metabolism. Part 8. The pyranocoumarin, decursin. Chem Pharm Bull 2007; 55: 1512-1513
• 19 Kim KM, Kim MJ, Kang JS. Absorption, distribution, metabolism, and excretion of decursin and decursinol angelate from Angelica gigas Nakai. J Microbiol Biotechnol 2009; 19: 1569-1572
• 20 Seo YJ, Kwon MS, Park SH, Sim YB, Choi SM, Huh GH, Lee JK, Suh HW. The analgesic effect of decursinol. Arch Pharm Res 2009; 32: 937-943
• 21 Son SH, Kim MJ, Chung WY, Son JA, Kim YS, Kim YC, Kang SS, Lee SK, Park KK. Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase. Cancer Lett 2009; 280: 86-92
• 22 Abdullayeva R, Ganiyev M, Asmetov V. Effects of diumancal and decursinol on 5-hydroxytryptamine level in rat brain. Georgian Med News 2009; 84-88
• 23 Lee HJ, Lee EO, Lee JH, Lee KS, Kim KH, Kim SH, Lu J. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. Am J Chin Med 2009; 37: 127-142
• 24 Oh JH, Park SE, Shim CK, Lee YJ. Biliary clearance of bromosulfophthalein in anesthetized and freely moving conscious rat. Biopharm Drug Dispos 2009; 30: 94-98
• 25 Park RJ, Kim NJ, Lee KT, Seo SH. Comparative studies on concentration of decursinol in rat plasma after oral administration of Angelicae gigantis Radix extract and combined use of decursin and Cnidii Rhizoma extract or Bupleuri Radix extract in rats. Kor J Pharmacognosy 2001; 32: 72-78
• 26 Li L, Zhang J, Shaik AA, Zhang Y, Wang L, Xing C, Kim SH, Lu J. Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC. Planta Med 2012; 78: 252-259
• 27 Gibaldi M, Perrier D. Pharmacokinetics. New York: M. Dekker; 1982
• 28 Kwon Y. Handbook of essential pharmacokinetics, pharmacodynamics, and drug metabolism for industrial scientists. New York: Kluwer Academic/Plenum Publishers; 2001
• 29 Kang SY, Lee KY, Sung SH, Kim YC. Four new neuroprotective dihydropyranocoumarins from Angelica gigas . J Nat Prod 2005; 68: 56-59
• 30 Madgula VL, Avula B, Reddy VLN, Khan IA, Khan SI. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability. Planta Med 2007; 73: 330-335
• 31 Kim MK, Hyun SH, Choung SY. Effect of herbal extract mixtures on serum and liver lipid metabolism in chronic ethanol – administered rats. J Health Sci 2006; 52: 344-351
• 32 Ohshiro T, Namatame I, Lee EW, Kawagishi H, Tomoda H. Molecular target of decursins in the inhibition of lipid droplet accumulation in macrophages. Biol Pharm Bull 2006; 29: 981-984